naltrexone has been researched along with pf-04455242 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Badura, LL; Banerjee, A; Byon, W; Carson, RE; Grimwood, S; Huang, Y; Jacobsen, LK; Lin, SF; McCarthy, TJ; Nabulsi, N; Naganawa, M; Tomasi, G; Weinzimmer, D; Zheng, MQ | 1 |
1 other study(ies) available for naltrexone and pf-04455242
Article | Year |
---|---|
Evaluation of the agonist PET radioligand [¹¹C]GR103545 to image kappa opioid receptor in humans: kinetic model selection, test-retest reproducibility and receptor occupancy by the antagonist PF-04455242.
Topics: Adult; Biphenyl Compounds; Brain; Female; Humans; Kinetics; Male; Middle Aged; Models, Neurological; Naltrexone; Narcotic Antagonists; Piperazines; Positron-Emission Tomography; Pyrrolidines; Receptors, Opioid, kappa; Reproducibility of Results; Sulfonamides | 2014 |